Stephan Rosenkranz, MD, is an interventional cardiologist, and serves as the Head of the Pulmonary Hypertension (PH) Center at the University of Cologne, Germany, and also leads the Cologne Cardiovascular Research Center (CCRC). Professor Rosenkranz graduated from the Justus Liebig University in Giessen, Germany, before becoming a resident physician and research fellow at the University of Cologne. Following his PhD, he undertook a post-doctoral fellowship at Harvard Medical School, USA, before returning to Cologne. He is currently the Chair of the Working Group “Pulmonary Circulation and Right Ventricular Function” of the European Society of Cardiology. His research interests include (i) cardiopulmonary interaction and right ventricular function in left heart disease, and (ii) signal transduction and the biological importance of receptor tyrosine kinases and stress signalling in cardiovascular disease. He has been involved in numerous clinical trials in the fields of atherosclerosis, heart failure and PH, and received numerous scientific awards.